Tirzepatide's dual receptor mechanism How tirzepatide works: Dual GIP/GLP-1 receptor agonist Single molecule, two pathways GIP (glucose-dependent insulinotropic polypeptide) + GLP-1 Weekly subcutaneous injection FDA approved for diabetes and obesity GIP pathway effects: Enhances insulin secretion Improves insulin sensitivity Promotes fat metabolism Reduces inflammation Works synergistically with GLP-1 GLP-1 pathway effects: Suppresses appetite (central brain effects) Slows gastric emptying (moderate) Increases satiety Reduces glucagon Improves glucose control Combined tirzepatide results: 15-22% average body weight loss (monotherapy) Superior to semaglutide (GLP-1 alone) Well-tolerated in trials Approved and available See our tirzepatide dosing guide , semaglutide vs tirzepatide , and peptides for weight loss at SeekPeptides
These mutations can alter the enzymes effectiveness, potentially leading to health issues, earlier for some and over time for others
These three powerful bioactive peptides BPC-157, TB-500, and GHK-Cu (Copper Peptides) are revolutionizing how India treats aging, acne, hair loss, and skin repair
Not for use by: Pregnant or breastfeeding individuals
What ingredients work well with glutathione serum for dull skin
